Started Feb 15, 2019 06:00PM UTC   •   Closed Oct 01, 2019 06:59AM UTC

Will Bristol-Myers Squibb Corp.’s acquisition of Celgene Corp. close before 1 October 2019? 

On 3 January 2019, pharmaceutical company Bristol-Myers Squibb Corp. announced its planned $74 billion acquisition of biotechnology firm Celgene Corporation, expected by the third quarter of 2019 (CNBC, U.S Securities and Exchange Commission).

Confused? Check our FAQ or ask us for help.

The question closed "No" with a closing date of 1 October 2019.

See our FAQ to learn about how we resolve questions and how scores are calculated.

Answer was incorrect

Most Accurate

Accuracy Score